June 30, 2014 – Q3 Quarterly Report
http://www.otcmarkets.com/otciq/ajax/showFinancialReportById.pdf?id=124991
List of Relevant Transactions for this Section:
2/12/13: 1,000,000 common shares sold to W. Scott Rombach, CompuMed’s President, CEO and Director, at a market price of $0.09 per share for total proceeds of $90,000. These shares carry restricted legends.
5/13/13: 750,000 common shares sold to W. Scott Rombach, CompuMed’s President, CEO and Director, at a market price of $0.08 per share for total proceeds of $60,000. These shares carry restricted legends.
6/25/14: 133,333 common shares sold to Dr. John Romm, a former Director, exercised stock option grants, at a grant price of $0.16 per share for total proceeds of $21,333.28. These shares carry no restrictive legends.
6/25/14: 133,333 common shares sold to Dr. John Romm, a former Director, exercised stock option grants, at a grant price of $0.16 per share for total proceeds of $21,333.28. These shares carry no restrictive legends.
6/26/14: 250,000 common shares sold to Robert Stuckelman, former Director, exercised stock option grants, at a grant price of $0.16 per share for total proceeds of $40,000. These shares carry no restrictive legends.
6/27/14: 200,000 common shares sold to Dr. Stuart Silverman, a former Director, exercised stock option grants, at a grant price of $0.16 per share for total proceeds of $32,000. These shares carry no restrictive legends.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM